BANK VONTOBEL/CALL/FRESENIUS MEDICAL CARE/55/1/20.12.24 Stock

Warrant

DE000VM04JF8

Delayed Deutsche Boerse AG 04:34:24 2024-07-11 EDT
0.001 EUR 0.00% Intraday chart for BANK VONTOBEL/CALL/FRESENIUS MEDICAL CARE/55/1/20.12.24
1 month-99.70%
3 months-99.74%
Date Price Change
24-07-11 0.001 0.00%
24-07-10 0.001 0.00%
24-07-09 0.001 0.00%
24-07-08 0.001 -50.00%
24-07-05 0.002 -50.00%

Delayed Quote Deutsche Boerse AG

Last update July 11, 2024 at 04:34 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VM04JF
ISINDE000VM04JF8
Date issued 2023-08-11
Strike 55
Maturity 2024-12-20 (163 Days)
Parity 1 : 1
Emission price 4.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.74
Lowest since issue 0.001
Spread 0.072
Spread %98.63%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.22 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.36%
Consensus